OrthoPediatrics Q2 2024 Adj. EPS $(0.23) Beats $(0.27) Estimate, Sales $52.802M Beat $52.495M Estimate
Author: Benzinga Newsdesk | August 05, 2024 04:28pm
OrthoPediatrics (NASDAQ:
KIDS) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.27) by 14.81 percent. The company reported quarterly sales of $52.802 million which beat the analyst consensus estimate of $52.495 million by 0.59 percent. This is a 33.48 percent increase over sales of $39.559 million the same period last year.
Posted In: KIDS